Fox Run Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,575
Closed -$1.34M 957
2022
Q3
$1.34M Buy
30,575
+26,034
+573% +$1.26M 0.52% 10
2022
Q2
$223K Buy
+4,541
New +$244K 0.11% 393
2019
Q4
Sell
-3,583
Closed -$227K 568
2019
Q3
$227K Buy
+3,583
New +$224K 0.21% 259
2019
Q1
Sell
-4,076
Closed -$202K 746
2018
Q4
$202K Sell
4,076
-6,867
-63% -$413K 0.11% 409
2018
Q3
$777K Buy
+10,943
New +$696K 0.34% 38
2018
Q1
Sell
-25,115
Closed -$1.47M 984
2017
Q4
$1.47M Buy
+25,115
New +$1.42M 0.43% 11

Other funds holding NUVA

Fox Run Management's NUVA Position: Q4 2022 in Review

Fox Run Management sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 30,575 shares — an estimated $1.34M sold.

Fox Run Management first reported a position in NUVA in Q4 2017 and held it in 6 quarters. The position peaked at $1.47M in Q4 2017. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

  • Fox Run Management reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
  • Fox Run Management sold 30,575 NuVasive, Inc. shares in Q4 2022, an estimated $1.34M.
  • Fox Run Management first reported a position in NuVasive, Inc. in Q4 2017 and held it in 6 quarters.
  • Fox Run Management's NuVasive, Inc. position peaked at $1.47M in Q4 2017.
  • 235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.